Le Lézard
Classified in: Health
Subject: MAT

Pine Grove Behavioral Health & Addiction Services earns Three-Year CARF Accreditation


CARF International announces Pine Grove Behavioral Health & Addiction Services accreditation.

HATTIESBURG, Miss., Oct. 5, 2022 /PRNewswire-PRWeb/ -- CARF International announced that Pine Grove Behavioral Health & Addiction Services has been accredited for a period of three years for its adult Intensive Outpatient Treatment: Substance Use Disorders (SUD) program, the Partial Hospitalization: Integrated: SUD / Mental Health treatment program for adults, and its Residential Treatment: Integrated: SUD / Mental Health treatment program for adults.

This is the first accreditation that the international accrediting body, CARF, has given to Pine Grove. This accreditation was the result of a concentrated team effort on Pine Grove's behalf. Debbie Sanford, RN, MS, MBA, Pine Grove's Administrator said, "I am very appreciative of every Pine Grove staff member, who contributed many hours towards this accreditation, checking charts, writing policies, and ensuring staff education and competencies. This important achievement certainly took the whole Pine Grove team coming together."

This accreditation decision represents the highest level of accreditation that can be given to an organization and shows the organization's substantial conformance to the CARF standards. An organization receiving a Three-Year Accreditation has put itself through a rigorous peer review process. It has demonstrated to a team of surveyors during an on-site visit its commitment to offering programs and services that are measurable, accountable, and of the highest quality.

Located in South Mississippi, Pine Grove Behavioral Health & Addiction Services is one of the nation's most comprehensive treatment campuses. Pine Grove's world renowned programs treat gender specific substance abuse including specialized tracks for co-occurring eating disorders and trauma. Additionally, Pine Grove offers an Intensive Outpatient substance abuse healing program for adults and a separate treatment track specifically for those who are age 55 plus. Other Pine Grove specialty programs include a dedicated professional's treatment curriculum and a comprehensive evaluation center. Pine Grove also features a program for patients with sexual addiction. Inpatient Services including an Adult Psychiatric Unit, along with a Child and Adolescent Psychiatric Unit, and Outpatient Services are other components. Pine Grove is a division of Forrest Health, a partnership of healthcare organizations across South Mississippi, and the behavioral healthcare extension of Forrest General Hospital, a 547 bed, level II Regional Trauma Center. Established in 1984, Pine Grove has provided nationally and internationally recognized health care for 38 years. For more information, please visit http://www.pinegrovetreatment.com and call 1-888-574-HOPE (4673).

CARF is an independent, nonprofit accrediting body whose mission is to promote the quality, value, and optimal outcomes of services through a consultative accreditation process and continuous improvement services that center on enhancing the lives of the persons served. Founded in 1966 as the Commission on Accreditation of Rehabilitation Facilities, and now known as CARF International, the accrediting body establishes consumer-focused standards to help organizations measure and improve the quality of their programs and services. For more information about the accreditation process, please visit the CARF website at http://www.carf.org.

Media Contact

Colleen Munkel, Pine Grove Behavioral Health & Addiction Services, 1 601-288-4834, [email protected]

 

SOURCE Pine Grove Behavioral Health & Addiction Services


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: